Re: Symptoms of dioxin Part 2/3

[GCJeffrey@aol.com]

"Dr Aziz," "Indigenous Environmental
Network"  and Neil Tangri

Porphyria Cutanea Tarda is a symptom
of dioxin toxicity.  Other Porphyrias
such as VP and AIP have also been
noted in dioxin exposed workers such
as paper mill chemists.

PCT is included in the following from
CIIN's "Our Toxic Times" Monthly.
http://biz-comm.com/CIIN/

Cynthia Wilson's group publishes OTT
and also wrote "Chemical Exposure and
Human Health".


Ref. 14 Symptoms,  Porphyria Endocrine Disruption

Many Pesticides and Chemical Warfare Agents are
designed to be porphyrinogenic.

We should not expose our children and adults to
porphyrinogenic substances like dioxin which
cause costly, disabiling gene damage.
Notice how many school and social behavioral
symptoms are in the following lists for untreated toxic
conditions associated with dioxin and related
chemicals.


============================
Dr. William Morton has estimated that better testing
(and probable continuing damage to the US gene pool
like related diabetes) has raised the porphyria rate
estimated from less than 1% to as much as 9% of the
population.

Redefinition of Abnormal Susceptibility to
Environmental Chemicals by Dr. William E. Morton.
This study looks at the porphyrin abnormalities in
MCS. $4.40 Order No. 0112-MORT-95-018R
http://biz-comm.com/CIIN/  Click on Library



Porphyria
==============================
[277.1] __ Disorders of porphyrin metabolism

Symptoms:

[277.1-1] __   Abdominal pain
[277.1-2] __   Abdominal tenderness
[277.1-3] __   Arosclerosis (sp) (scleradema
                       [sp] of the upper extremities,
                       sometimes extending to the
                       neck and face)
[277.1-4] __   Alopecia (hair loss)
[277.1-5] __   Anemia; hypochromic, microcytic
[277.1-6] __   Amenorrhea (absence or
                      suppression of menstruation)
[277.1-7] __  Anemia, hemolytic
[277.1-8] __   Anxiety
[277.1-9] __   Aphonia (inability to produce
                       sound)
[277.1-10] __   Appetite, loss of
[277.1-11] __   Back Pain
[277.1-12] __   Behavioral change
[277.1-13] __   Bladder distention
[277.1-14] __   Bowel incontinence
[277.1-15] __   Breast secretions
[277.1-16] __   Carbohydrate craving
[277.1-17] __   Cardiac arrest
[277.1-18] __   Central nervous system lesions
[277.1-19] __   Chest pain
[277.1-20] __   Coma
[277.1-21] __   Confusion
[277.1-22] __   Conjunctivitis
[277.1-23] __   Constipation
[277.1-24] __   Corneal inflammation
[277.1-25] __   Delirium
[277.1-26] __   Depression
[277.1-27] __   Diarrhea
[277.1-28] __   Disorientation
[277.1-29] __   Dysphasia (inability or difficulty
                     swallowing)
[277.1-30] __   Extremities become painful
[277.1-31] __   Facial hair, excessive
[277.1-32] __   Fatigue
[277.1-33] __   Fecal impaction
[277.1-34] __   Fever
[277.1-35] __   Foot drop
[277.1-36] __   Gag reflex, depressed
[277.1-37] __   Gastrointestinal spasms
[277.1-38] __   Hallucinations
[277.1-39] __   Hyperpigmentation
[277.1-40] __   Hypertension (high blood
                         pressure)
[277.1-41] __   Hypoesthesia (sp)  (dulled
                         sensitivity to touch)
[277.1-42] __   Hyponatraemia (sp)
                         (decrease sodium in blood)
[277.1-43] __   Hypotension, postural
                         decrease in blood pressure
                         upon assuming an erect
                         posture)
[277.1-44] __   Ileus (obstruction of the
                         intestines)
[277.1-45] __   Insomnia
[277.1-46] __   Irritability
[277.1-47] __   Jaundice
[277.1-48] __   Joint pain or stiffness
[277.1-49] __   Limb stiffness
[277.1-50] __   Menstruation often
                         exacerbates symptoms
[277.1-51] __   Mood changes
[277.1-52] __   Muscle cramps
[277.1-53] __   Muscle pain or stiffness
[277.1-54] __   Nausea
[277.1-55] __   Nerve palsy; accessory,
                         bulbar, facial, hypoglossal,
                         trigeminal loss of the
                         ability to move or control
                         movement)
[277.1-56] __   Nightmares
[277.1-57] __   Organic brain syndrome
[277.1-58] __   Panic attacks
[277.1-59] __   Paralysis, partial
[277.1-60] __   Paralysis, temporary
[277.1-61] __   Paresthesia (numbness or
                         tingling sensation)
[277.1-62] __   Peripheral motor deficits
[277.1-63] __   Peripheral neuropathy
[277.1-64] __   Photosensitivity (porphyrins
                         interacting with sunlight
                         causing neurologic and/or
                         skin problems)
[277.1-65] __   Polyneuropathy
[277.1-66] __   Psychosis
[277.1-67] __   Restlessness
[277.1-68] __   Respiration, decreased
[277.1-69] __   Respiratory paralysis
[277.1-70] __   Retinal artery spasm
[277.1-71] __   Seizures (convulsions)
[277.1-72] __   Sensory disorders
[277.1-73] __   Skin lesions, blisters, or ulcers
[277.1-74] __   Sweating, profuse
[277.1-75] __   Tachycardia (heart rate of
                          over 100 beats per minute)
[277.1-76] __   Tendon reflexes, absent or
                         depressed
[277.1-77] __   Tremors
[277.1-78] __   Urinary incontinence
[277.1-79] __   Urine, changes in color of
                          (usually red, brown, or green)
[277.1-80] __   Urine retention
[277.1-81] __   Urine formation, absence of
                          (Oliguria)
[277.1-82] __   Vision, changes in
[277.1-83] __   Voice, weakness
[277.1-84] __   Vomiting
[277.1-85] __   Weakness
[277.1-86] __   Wrist drop


The use of this survey is not a substitute for
medical, legal or other professional services.
Consult competent professionals for application,
confirmation of this information and for
answers to your specific questions.
Various other disclaimers and suggestions
are present in various toxicology reference
books, etc.